Navigation Links
Human Genome Sciences to Receive $9 Million Milestone Payment Related to GlaxoSmithKline Initiation of Phase 3 Clinical Trial of Syncria(R) in Type 2 Diabetes
Date:2/17/2009

ROCKVILLE, Md., Feb. 17 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that GlaxoSmithKline (NYSE: GSK) has initiated a Phase 3 clinical trial program to evaluate the efficacy, safety and tolerability of Syncria(R) (albiglutide) in the long-term treatment of type 2 diabetes mellitus. As a result, HGS will receive a $9 million milestone payment in the first quarter of 2009.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO )

"We are delighted that GSK has advanced Syncria to Phase 3 development, and we look forward to the future progress of this important program," said H. Thomas Watkins, President and Chief Executive Officer, HGS.

Syncria is the fifth product to which HGS has substantial financial rights that has entered late-stage clinical development. It is a biological product generated from the genetic fusion of human albumin and modified human GLP-1 peptide, and is designed to act throughout the body to help maintain normal blood-sugar levels and to control appetite. Syncria was created by HGS using its proprietary albumin-fusion technology, and licensed to GSK in 2004. HGS is entitled to fees and milestone payments that could amount to as much as $183 million - including $24 million received to date - in addition to single-digit royalties on worldwide sales if Syncria is commercialized.

Attached is a press release issued earlier this morning by GSK (http://tinyurl.com/crprkt) announcing initiation of the Phase 3 program for Syncria. All inquiries regarding the dev
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. China Biologic Products High-Purity Human Albumin Research and Development Project to be Listed in the National Torch Plan
2. 14th Annual Wharton Health Care Business Conference to Feature CEOs from WebMD, McKesson, Humana and Given Imaging
3. Victhom Human Bionics Receives CE Mark for the Neurostep(TM) System, the Worlds First Fully Implantable Closed-Loop Neuromodulation Therapy for Treatment of Foot Drop
4. ArunA Biomedical Announces Commercial Release of its Human Embryonic Stem Cell Derived Neural Cells
5. Modigene Awarded Second-Year Grant by Israeli Government to Support Development of Its Longer-Acting Human Growth Hormone
6. Victhom Human Bionics Neurobionix Division receives ISO 13485:2003 Certification for its Design Control System
7. MultiVu Video Feed: Geron Receives FDA Clearance to Begin Worlds First Human Clinical Trial of Embryonic Stem Cell-Based Therapy
8. Rules-Based Medicine, Inc. Launches Human Kidney Damage Biomarker Panel
9. Human Genome Sciences Announces Initiation of Phase 2b Trial of Albuferon(R) Dosed Monthly in Chronic Hepatitis C
10. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JPMorgan Conference
11. Human Genome Sciences Announces Albuferon(R) Meets Primary Endpoint in Phase 3 Trial in Chronic Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... DUBLIN , Aug. 27, 2014 ... of the "Global Lactic Acid  (Biodegradable Polymer, ... - Trends & Forecasts to 2019" report ... the simplest hydroxyl-carboxylic acid with an asymmetrical carbon ... in the biodegradable polymer, food and beverage, personal ...
(Date:8/27/2014)... “We are honored to be named ... Thangaraj, CEO of Radiant Sage. “We are offering truly ... imaging corelab market to a different level. We ... to efficiently and effectively manage the massive amounts of ... analyzed and read by trained physicians. Being recognized by ...
(Date:8/27/2014)... CO (PRWEB) August 27, 2014 Flagship ... analysis services to the pharmaceutical and medical device ... expansion. The fast growing company has consolidated its ... Aurora and Boulder to Westminster, CO, just north of ... Histology Lab, 7575 W. 103rd Ave., Suite 100, Westminster, ...
(Date:8/27/2014)...  ARCH Venture Partners, one of the largest ... of seed and early-stage advanced technology companies, today ... more than $400 million in subscriptions. ARCH Venture ... by more than $150 million. "The ... potential of our approach to finding and funding ...
Breaking Biology Technology:Global Lactic Acid (Biodegradable Polymer, Food & Beverage, Personal Care & Pharmaceutical) Market - Trends & Forecasts to 2019 2Radiant Sage Named to CIOReview List of 100 Most Promising Technology Companies 2Flagship Biosciences Announces Relocation and Expansion 2Latest ARCH Venture Partners Fund Closes Above $400 Million 2Latest ARCH Venture Partners Fund Closes Above $400 Million 3
... Aperio , ... that improve patient care, and Definiens , the ... in which Aperio will market Definiens Tissue Studio™ ... digital pathology, on a worldwide, non-exclusive basis. ...
... 2011 SeraCare Life Sciences, Inc. (NASDAQ: ... products and services to facilitate the discovery, development and ... election of Joseph Nemmers and Kevin Hrusovsky to its ... has been appointed to the position of Chairman of ...
... OncoSec Medical Inc. (OTCBB: ONCS), a therapeutic oncology ... tumor cancers that have unmet medical needs, announced ... leadership team. Formed earlier this year, OncoSec expects ... tumor-destroying, tissue-sparing ElectroOncology therapies before the end of ...
Cached Biology Technology:Aperio Partners with Definiens to Market Definiens Tissue Studio for Advanced Image Analysis 2Aperio Partners with Definiens to Market Definiens Tissue Studio for Advanced Image Analysis 3Aperio Partners with Definiens to Market Definiens Tissue Studio for Advanced Image Analysis 4SeraCare Announces the Election of Joseph Nemmers and Kevin Hrusovsky to the Board of Directors 2SeraCare Announces the Election of Joseph Nemmers and Kevin Hrusovsky to the Board of Directors 3SeraCare Announces the Election of Joseph Nemmers and Kevin Hrusovsky to the Board of Directors 4OncoSec Announces Leadership Team Appointments 2OncoSec Announces Leadership Team Appointments 3OncoSec Announces Leadership Team Appointments 4
(Date:8/27/2014)... a new skill is easier when it is related ... trained pianist might learn a new melody more easily ... Neural engineers from the Center for the Neural Basis ... Pittsburgh and Carnegie Mellon Universityhave discovered a fundamental constraint ... Published as the cover story in the Aug. 28, ...
(Date:8/27/2014)... grass species frequently found in forests has created a ... American toads, a new University of Georgia study has ... the U.S. in the early 1900s, is one of ... more than a dozen states in the past century, ... in forests, it can survive in widely diverse ecosystems ...
(Date:8/27/2014)... N.C. -- When we want to listen carefully to ... The second thing we do is stop moving altogether. ... sounds generated by our own movements. , This interplay ... in the brain. Indeed, indirect evidence has long suggested ... influences the auditory cortex, which gives rise to our ...
Breaking Biology News(10 mins):Pitt and Carnegie Mellon engineers discover why learning can be difficult 2Pitt and Carnegie Mellon engineers discover why learning can be difficult 3More wolf spiders feasting on American toads due to invasive grass, UGA study shows 2More wolf spiders feasting on American toads due to invasive grass, UGA study shows 3Stop and listen: Study shows how movement affects hearing 2Stop and listen: Study shows how movement affects hearing 3
... how two closely related proteins guide projections from nerve ... axons as they navigate the most miniscule and frenetic ... connections. The discovery, reported April 28 in the ... the "semaphorin" family of guidance cues are crucial for ...
... for coeliac disease has shown promising results for treating coeliac ... to move to Phase II trials within the next year. ... the safety, tolerability and bioactivity of the vaccine Nexvax2, which ... autoimmune disease caused by an immune reaction to the gluten ...
... of Global Change Biology Bioenergy outlines a ... issues surrounding the rapidly evolving race to develop biofuels. ... on Bioethics Working Party on Biofuels, and Scientific Adviser ... the Council,s proposed development of a comprehensive ethical standard ...
Cached Biology News:Johns Hopkins scientists reveal nerve cells' navigation system 2Johns Hopkins scientists reveal nerve cells' navigation system 3Celiac disease vaccine shows promising results in Phase I trial 2
... Lambda Protein Phosphatase ... Mn2+-dependent protein phosphatase with ... threonine and tyrosine residues. ... amino-acid product of the ...
... Innovative HL-2000 HybriLinker combines the benefits of a ... self-contained, space saving unit. , ... Laboratory allows crosslinking ,and hybridization at one location ... HL-2000 operate independently of each other , ...
... a wide variety of solvent vapors that can ... condensation flask (GCF400) allows for the collection of ... draining. Rapid cooling time minimizes waiting period., ... solvent changes , -50?C ...
... determined by Biuret Physical form: Solution in ... 7.6, 1 mM MgCl 2 and ... Definition: One unit will hydrolyze 1 μmole ... 9.8 at 37 C. • Concentration: ≥ ...
Biology Products: